SIGNA Architect Recall
SIGNA Architect
FDA recall Class II
Ongoing
FDA lists this Class II recall for SIGNA Architect. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2130-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- May 23, 2025
- FDA report date
- Jul 30, 2025
- Quantity in commerce
- N/A
- Distribution
- See key details
- FDA cause
- Device Design
What is being recalled?
SIGNA Architect
Affected model & UDI checker
Search the exact identifiers published for Z-2130-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | SIGNA Architect | Check source notice | 00840682147095 |
| Not specified | SIGNA Architect | Check source notice | 00840682122702 |
| Not specified | SIGNA Architect | Check source notice | 00195278023643 |
| Not specified | SIGNA Architect | Check source notice | 00840682123440 |
FDA code information
GTIN: 00840682147095 00840682122702 00195278023643 00840682123440
Why was this product recalled?
GE HealthCare has become aware that gradient coils for certain MR systems (see affected product list in this letter), under specific conditions, can produce elevated acoustic noise during scanning. As a result, acoustic levels can exceed 99dB, the limit established by International Electrotechnical Commission (IEC 60601-2-33) when using hearing protection with a Noise Reduction Rating (NRR) of 29dB, as currently required in the Operator Manual.
What actions did GE Medical Systems, LLC take?
GE Healthcare issued an URGENT MEDICAL DEVICE CORRECTION to its consignees on 05/23/2025 delivered using traceable means. The notice explained the issue, risk, and requested the following: Actions to be taken by Customer/User: You can continue to use your MR system by following the instructions below: Ensure hearing protection with a Noise Reduction Rating (NRR) of at least 33dB is used during exams on these systems. 200 pairs are provided with this letter. Please post this letter in your facility on or near the MR operator console. Please ensure all potential users in your facility are made aware of this safety notification and the recommended actions. Please retain this document for your records. Please complete and return the attached acknowledgement form to [email protected].
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2130-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology